Trial no.:
|
PACTR202402735520583 |
Date of Approval:
|
13/02/2024 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Intramuscular Pentazocine Versus Rectal Diclofenac for Pain Relief after Caesarean Section.
|
Official scientific title |
Intramuscular Pentazocine versus Rectal Diclofenac for Pain Relief after Caesarean Section: A Randomized Control Trial
|
Brief summary describing the background
and objectives of the trial
|
Background:
Caesarean section (CS) commonly causes moderate to severe pain in the first 48 hours after surgery with associated discomfort, delayed ambulation, difficulty initiating breastfeeding and prolonged hospital stay. Adequate analgesia after caesarean section is thus very important for the patient’s comfort, overall wellbeing and recovery.
Objective:
To compare the analgesic effectiveness of rectal diclofenac with intramuscular Pentazocine in the reduction of pain following caesarean section in Federal Medical Centre, Keffi. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Obstetrics and Gynecology |
Sub-Disease(s) or condition(s) being studied |
caeserean section |
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
02/03/2023 |
Actual trial start date |
15/03/2023 |
Anticipated date of last follow up |
30/09/2023 |
Actual Last follow-up date |
20/10/2023 |
Anticipated target sample size (number of participants) |
240 |
Actual target sample size (number of participants) |
240 |
Recruitment status |
Completed |
Publication URL |
|
|